As shown in Figure 4C, glioma patients with high SIGLEC9 expression have significantly enhanced infiltration of immune cells, such as T cells, NK cells, neutrophils, aDC, B cells, DC cells, iDC cells, macrophages, mast cells, Th1, Th2, Th17, and so on. This evidence concerns the gene SIGLEC9 and glioma.